Chemical Compound
8-Isoprostaglandin E1; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (8ss,11a,13E,15S)-; Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, stereoisomer (8CI); (8ss,11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; 11a,15-(S)-Dihydroxy-9-oxo-13-trans-
CAS Registry Number
21003-46-3
Primary record
8-Isoprostaglandin E1; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (8ss,11a,13E,15S)-; Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, stereoisomer (8CI); (8ss,11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; 11a,15-(S)-Dihydroxy-9-oxo-13-trans-
- 库存
- 5,586 克
- 纯度
- 99.5 %
- CAS
- 21003-46-3
化合物标识与属性
- CAS
- 21003-46-3
- PubChem CID
- 5283212
- SMILES
- CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@H]1CCCCCCC(=O)O)O)O
- Canonical SMILES
- CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@H]1CCCCCCC(=O)O
名称与同义词
- 8-iso Prostaglandin E1
- Ovinonic acid
- Isoprostaglandin E1
- 8-iso-PGE1
- alprostadil
- Iso-PGE1
- Prostaglandin E1
- 8-epiprostaglandin E1
- 8-Isoprostaglandin E1
- 21003-46-3
- 8-epi-Prostaglandin E1
- Prostaglandin Impurity 2
- AC1NR1RT
- 8-ISOPROSTAGLANDINE1
- RefChem:906302
- 11beta-Prostaglandin E1
- 84W5RE239W
- 15(R)-Prostaglandin E1
- UNII-84W5RE239W
- (-)-8-epi-PGE1
- Alprostadil EP Impurity F 1
- 15-EPI PGE1
- DTXSID901185206
- orb1985078
- SCHEMBL11558861
- CHEBI:183841
- GMVPRGQOIOIIMI-JCPCGATGSA-N
- DTXCID401616533
- HMS3648O22
- C20H34O5
- ZINC5978187
- LMFA03110002
- MFCD00065736
- AKOS040755085
- CID5283212
- Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (8beta,11alpha,13E,15S)-
- J16.435F
- PD021223
- DB-215084
- HY-118094
- 7-[(1S,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
- ALPROSTADIL IMPURITY F [EP IMPURITY]
- CS-0065185
- FT-0603510
- FT-0638061
- FT-0638072
- FT-0638434
- SR-01000946396
- SR-01000946396-1
- Q27269559
- 11a,15-(S)-Dihydroxy-9-oxo-13-trans-8-isoprostenoate
- 9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid-cyclo[8S,12R]
- (8beta,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- 11a,15-(S)-Dihydroxy-9-oxo-13-trans-8-isoprostenoic acid
- 11alpha,15-(S)-Dihydroxy-9-oxo-13-trans-8-isoprostenoic acid
- (13E,15S)-11alpha,15-Dihydroxy-9-oxo-8beta-prost-13-en-1-oic acid
- (8Beta,11alpha,13e,15s)-11,15-dihydroxy-9-oxo-prost-13-en-1-oic acid
- (8beta,13E,15S)-11alpha,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- (8I(2),11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- (8S,11R,13E,15S)-9-Oxo-11,15-dihydroxyprosta-13-ene-1-oic acid
- 9-OXO-11ALPHA,15S-DIHYDROXY-(8BETA)-PROST-13E-EN-1-OIC ACID
- 7-[(1S,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
- 7-[(1S,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
- 20897-91-0
- 24570-01-2
- 7-[(1S,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid
- 745-65-3
- 8-Isoprostaglandin E1; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (8ss,11a,13E,15S)-; Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, stereoisomer (8CI); (8ss,11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; 11a,15-(S)-Dihydroxy-9-oxo-13-trans-